Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.

appropriate-for-gestational-age bronchopulmonary dysplasia preterm infant pulmonary oxygen diffusion small-for-gestational-age

Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
11 2023
Historique:
revised: 07 06 2023
received: 25 02 2023
accepted: 19 07 2023
medline: 23 10 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

Small-for-gestational-age (SGA) preterm infants are at increased risk of developing bronchopulmonary dysplasia (BPD). There is limited information on pulmonary oxygen diffusion of SGA preterm infants, particularly in those without BPD. To compare the pulmonary oxygen diffusion of SGA to that of appropriate-for-gestational-age (AGA) preterm infants without BPD. Preterm infants with a gestational age (GA) between 24.0 and 31.6 weeks were studied. The oxygen saturation (SpO We analyzed 1189 infants surviving at 36 weeks: 194 (16%) were SGA and 995 (84%) AGA. The incidence of BPD was significantly higher in SGA than AGA infants (32% vs. 13%; p = .000). Out of the 995 infants without BPD, 132 (13%) were SGA and 863 (87%) AGA. SGA was negatively associated with the SFR value at 36 weeks, independently from BPD. SGA infants without BPD had significantly higher (better) SFR at birth, but lower (worse) SpO Among preterm infants of less than 32 weeks and without BPD, SGA infants had a reduced pulmonary oxygen diffusion at 36 weeks in comparison with AGA infants.

Sections du résumé

BACKGROUND
Small-for-gestational-age (SGA) preterm infants are at increased risk of developing bronchopulmonary dysplasia (BPD). There is limited information on pulmonary oxygen diffusion of SGA preterm infants, particularly in those without BPD.
OBJECTIVE
To compare the pulmonary oxygen diffusion of SGA to that of appropriate-for-gestational-age (AGA) preterm infants without BPD.
STUDY DESIGN
Preterm infants with a gestational age (GA) between 24.0 and 31.6 weeks were studied. The oxygen saturation (SpO
RESULTS
We analyzed 1189 infants surviving at 36 weeks: 194 (16%) were SGA and 995 (84%) AGA. The incidence of BPD was significantly higher in SGA than AGA infants (32% vs. 13%; p = .000). Out of the 995 infants without BPD, 132 (13%) were SGA and 863 (87%) AGA. SGA was negatively associated with the SFR value at 36 weeks, independently from BPD. SGA infants without BPD had significantly higher (better) SFR at birth, but lower (worse) SpO
CONCLUSION
Among preterm infants of less than 32 weeks and without BPD, SGA infants had a reduced pulmonary oxygen diffusion at 36 weeks in comparison with AGA infants.

Identifiants

pubmed: 37594147
doi: 10.1002/ppul.26620
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3054-3062

Informations de copyright

© 2023 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.

Références

Qiu X, Lodha A, Shah P, et al. Neonatal outcomes of small for gestational age preterm infants in Canada. Am J Perinatol. 2012;29(2):87-94.
Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of intrauterine growth restriction and small for gestational age status with childhood cognitive outcomes: a systematic review and meta-analysis. JAMA Pediatr. 2020;174(8):772-781.
Sehgal A, Bhatia R, Roberts CT. Cardiovascular response and sequelae after minimally invasive surfactant therapy in growth-restricted preterm infants. J Perinatol. 2020;40(8):1178-1184.
Tsai LY, Chen YL, Tsou KI, Mu SC. The impact of small-for-gestational-age on neonatal outcome among very-low-birth-weight infants. Pediatr Neonatol. 2015;56(2):101-107.
Torrance HL, Voorbij HAM, Wijnberger LD, van Bel F, Visser GHA. Lung maturation in small for gestational age fetuses from pregnancies complicated by placental insufficiency or maternal hypertension. Early Hum Dev. 2008;84(7):465-469.
Peacock JL, Lo JW, D'Costa W, Calvert S, Marlow N, Greenough A. Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely. Pediatr Res. 2013;73(4 pt 1):457-463.
Harding R, Cock ML, Louey S, et al. The compromised intra-uterine environment: implications for future lung health. Clin Exp Pharmacol Physiol. 2000;27(12):965-974.
Vik T, Vatten L, Markestad T, Ahlsten G, Jacobsen G, Bakketeig LS. Morbidity during the first year of life in small for gestational age infants. Arch Dis Child Fetal Neonatal Ed. 1996;75(1):F33-F37.
Lanciotti L, Pasqualini M, Correani A, et al. Who needs a second dose of exogenous surfactant? J Pediatr. 2023;261:113535.
Rocha G, de Lima FF, Machado AP, et al. Small for gestational age very preterm infants present a higher risk of developing bronchopulmonary dysplasia. J Neonatal Perinatal Med. 2020;12(4):419-427.
Dravet-Gounot P, Torchin H, Goffinet F, et al. Bronchopulmonary dysplasia in neonates born to mothers with preeclampsia: impact of small for gestational age. PLoS One. 2018;13(9):e0204498.
Nobile S, Marchionni P, Carnielli VP. Neonatal outcome of small for gestational age preterm infants. Eur J Pediatr. 2017;176(8):1083-1088.
Hummler H, Sanchez-Luna M, Carnielli V, et al. Inhaled nitric oxide for premature babies-authors' reply. Lancet. 2010;376(9757):1985-1986.
Collins CT, Makrides M, McPhee AJ, et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N Engl J Med. 2017;376(13):1245-1255.
Greenough A, Yuksel B, Cheeseman P. Effect of in utero growth retardation on lung function at follow-up of prematurely born infants. Eur Respir J. 2004;24(5):731-733.
Hoo AF, Stocks J, Lum S, et al. Development of lung function in early life: influence of birth weight in infants of nonsmokers. Am J Respir Crit Care Med. 2004;170(5):527-533.
den Dekker HT, Sonnenschein-van der Voort AMM, de Jongste JC, et al. Early growth characteristics and the risk of reduced lung function and asthma: A meta-analysis of 25,000 children. J Allergy Clin Immunol. 2016;137(4):1026-1035.
Kotecha SJ, Watkins WJ, Heron J, Henderson J, Dunstan FD, Kotecha S. Spirometric lung function in school-age children: effect of intrauterine growth retardation and catch-up growth. Am J Respir Crit Care Med. 2010;181(9):969-974.
Saad NJ, Patel J, Burney P, Minelli C. Birth weight and lung function in adulthood: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(6):994-1004.
Kim YH, Kim KW, Eun HS, et al. Small for gestational age birth may increase airflow limitation in bronchopulmonary dysplasia. Pediatr Pulmonol. 2020;55(2):346-353.
Ronkainen E, Dunder T, Kaukola T, Marttila R, Hallman M. Intrauterine growth restriction predicts lower lung function at school age in children born very preterm. Arch Dis Child Fetal Neonatal Ed. 2016;101(5):F412-F417.
Arigliani M, Stocco C, Valentini E, et al. Lung function between 8 and 15 years of age in very preterm infants with fetal growth restriction. Pediatr Res. 2021;90(3):657-663.
Arigliani M, Valentini E, Stocco C, et al. Regional ventilation inhomogeneity in survivors of extremely preterm birth. Pediatr Pulmonol. 2020;55(6):1366-1374.
Correani A, Dell'Orto V, Nobile S, et al. Oxygen saturation to fraction of inspired oxygen ratio in preterm infants on routine parenteral nutrition with conventional or fish oil containing lipid emulsions. Pediatr Pulmonol. 2020;55(9):2377-2382.
Nobile S, Marchionni P, Gidiucci C, et al. Oxygen saturation/FiO2 ratio at 36 weeks' PMA in 1005 preterm infants: effect of gestational age and early respiratory disease patterns. Pediatr Pulmonol. 2019;54(5):637-643.
van der Burg PS, de Jongh FH, Miedema M, Frerichs I, van Kaam AH. Effect of minimally invasive surfactant therapy on lung volume and ventilation in preterm infants. J Pediatr. 2016;170:67-72.
Muniraman HK, Kibe R, Namjoshi A, et al. Evaluation of correlation and agreement between SpO2/FiO2 ratio and PaO2/FiO2 ratio in neonates. J Pediatr Intensive Care. Published online September 29, 2022. doi:10.1055/s-0042-1756716
Lanciotti L, Correani A, Pasqualini M, et al. Respiratory distress syndrome in preterm infants of less than 32 weeks: what difference does giving 100 or 200 mg/kg of exogenous surfactant make? Pediatr Pulmonol. 2022;57(9):2067-2073.
Bertino E, Di Nicola P, Varalda A, Occhi L, Giuliani F, Coscia A. Neonatal growth charts. J Matern-Fetal Neonatal Med. 2012;25(suppl 1):67-69.
Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114(5):1305-1311.
Di Fiore JM, Martin RJ, Li H, et al. Patterns of oxygenation, mortality, and growth status in the surfactant positive pressure and oxygen trial cohort. J Pediatr. 2017;186:49-56.
Amiel-Tison C, Cabrol D, Denver R, Jarreau PH, Papiernik E, Piazza PV. Fetal adaptation to stress. Early Hum Dev. 2004;78(1):15-27.
Procianoy RS, Garcia-Prats JA, Adams JM, Silvers A, Rudolph AJ. Hyaline membrane disease and intraventricular haemorrhage in small for gestational age infants. Arch Dis Child. 1980;55(7):502-505.
Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol. 2000;182(1 pt 1):198-206.
Gortner L, Wauer RR, Stock GJ, et al. Neonatal outcome in small for gestational age infants: do they really better? J Perinat Med. 1999;27(6):484-489.
Sharma P, McKay K, Rosenkrantz TS, Hussain N. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. BMC Pediatr. 2004;4:9.
Turitz A, Gyamfi-Bannerman C. Comparison of respiratory outcomes between preterm small-for-gestational-age and appropriate-for-gestational-age infants. Am J Perinatol. 2017;34(3):283-288.
Svedenkrans J, Stoecklin B, Jones JG, Doherty DA, Pillow JJ. Physiology and predictors of impaired gas exchange in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2019;200(4):471-480.
Thunqvist P, Tufvesson E, Bjermer L, et al. Lung function after extremely preterm birth-a population-based cohort study (EXPRESS). Pediatr Pulmonol. 2018;53(1):64-72.
Fainardi V, Sapienza E, Teopompi E, Pisi G, Magnani C, Chetta A. IOS in school-aged children born preterm: is small for gestational age a risk factor for small airway dysfunction? Eur Respir J. 2014;44(suppl 58):P1255.

Auteurs

Alessio Correani (A)

Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.
Division of Neonatology, Mother and Child Department, G. Salesi Children Hospital, Azienda Ospedaliero Universitaria delle, Ancona, Marche, Italy.

Lucia Lanciotti (L)

Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

Chiara Giorgetti (C)

Division of Neonatology, Mother and Child Department, G. Salesi Children Hospital, Azienda Ospedaliero Universitaria delle, Ancona, Marche, Italy.

Maria Laura Palazzi (ML)

Division of Neonatology, Mother and Child Department, G. Salesi Children Hospital, Azienda Ospedaliero Universitaria delle, Ancona, Marche, Italy.

Chiara Monachesi (C)

Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

Luca Antognoli (L)

Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.

Ilaria Burattini (I)

Division of Neonatology, Mother and Child Department, G. Salesi Children Hospital, Azienda Ospedaliero Universitaria delle, Ancona, Marche, Italy.

Paola Cogo (P)

Department of Medicine, University Hospital S Maria della Misericordia, University of Udine, Udine, Italy.

Virgilio Carnielli (V)

Department of Odontostomatologic and Specialized Clinical Sciences, Polytechnic University of Marche, Ancona, Italy.
Division of Neonatology, Mother and Child Department, G. Salesi Children Hospital, Azienda Ospedaliero Universitaria delle, Ancona, Marche, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH